Exposing Pump and Dumps - All my own opinions / not financial advice
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Lol I was positing a lot in the mid 4s buddy. Take the victory lap on buying low and selling high and touting your gains. Lol so funny and so obvious you got absolutely hosed but are trying to save face!
There was no offer, that would have had to of been disclosed. It’s a sh*t asset, that’s it. There’s nothing else to the story. The drug is sh*t, always has been and always will be. If you need to make up stories to feel better about yourself, go for it.
Investors were never mislead. The information was easily accessible, you just had to do some work ;) or pay attention when I post
See my older post. The drug is garbage and nobody wants this piece of trash.
Stink test? The company with the most data and transparency into the drug is dropping it. How does that’s not test the stink test? Fair Value is about $1
It will be much much much "cheaper" in 6 months. Fair Value is about $0.00001
I think GLXY is a screaming buy here
Very easy to get the bull case from any company, esp biotech company!. Just call them! I think you follow the smart HF and institutional money and its short. That is who you listen to
It is effectively the same drug as five years ago that has failed multiple different safety profiles.
Look at the investor base: all retail! The only institutional/sophisticated investors that show are up boxed longs.
So let's think, what do you know about the drug that the PhD/MDs running these HFs that are short don't?
Let's ask it in a different way: Why are you not running $2B biotech fund like these guys? Is it bc you just don't want to or is it bc their performance crushes yours bc they are professional investors?
Looking forward to hearing those comments. And before you say "they are manipulators." see my last post about companies that fight short sellers or blame short sellers and their long term performance...
Safety profile is trash
No real biotech investors are shareholders....
It’s all VIRTU trading and retail owned which is a great indicator of the knowledge base of the longs...
Haven't enrolled a patient since Oct 16', Janseen also changed the accounting for this company and downgraded it 20% from much higher... There are two substantiated claims, bud! If you want the bull case just go ask mgmt. Us short sellers like to keep our cookies and nuggets to ourselves but give people fair warning, like I have been here since 25% ago!
Crazy that its up over 100% last couple months but I posted two months ago I was short at $4.5.... Fair value is <$1. We will see in a couple months who is right and who is wrong! Can't wait to continue the streak!
LOL guys in the bioler room and pumping and then dumping stocks. Check my posts, I call out pumpers and dumpers. my track speaks for itself. Want me to go through yours to see how well you've done?
One of the HFs listed as a top shareholder, who is arguably one of the best smallcap biotech investors in the world, is short...this is simply a boxed position that shows up as a long
Only joke is this drug....Check the tape, bud. Look at all my posts. I have never been wrong when I publicly decide to say something is a short....
Fair value is about $0.70 so selling at $3.15 seems like a no-brainer.
Reasons why everything you just said is trash:
20x average daily trading vol with most coming from VIRTU, which is 100% retail. So this is unsophisticated money selling
See my last post, which is academic literature on why those companies that try to fight and blame short sellers go down a lot over time for fundamental reasons.
It’s a way to point fingers and blame others for betting on a crap asset and even worse Mgmt team
For those of you who blame short sellers for EVERYTHING....Great article to read to educate yourself
http://faculty.chicagobooth.edu/john.cochrane/teaching/Empirical_Asset_Pricing/lamont_go_down_fighting.pdf[faculty.chicagobooth.edu]
ABSTRACT
I study battles between short sellers and firms. Firms use a variety of methods to impede short selling, including legal threats, investigations, lawsuits, and various technical actions intended to create a short squeeze. These actions create short sale constraints. Consistent with the hypothesis
that short sale constraints allow stocks to be overpriced, firms taking anti-shorting actions have in the subsequent year very low abnormal returns of about -2 percent per month.
I covered my short months ago. If this ripped up to $1 again I would PILE into shorting it again
You need more than an audit, new market maker, new mgmt, etc. You need to sell and find a new company. Galaxy likely going public in the next couple of weeks. You want Crypto exposure? Buy that.
Also pls check my track record. I haven't been wrong. If I could short BITCF again, and not pay $0.10 a month to borrow, I would
I called this, I called LFIN, I called TRTCD, and most recently have called for the demise of GERN (avg cost is $4.5)
This thing is going back to sub 20. It’s been a massive squeeze on low float
They haven’t enrolled a new patient since Oct 2016.... this is a turd. JNJ will walk. I may cover some shares here just in case it rips back on no fundy news so I can short more.
Lol really? This pump and dump crap is still getting you all?
Make or lose ?? I think lose, bud.
This has intrinsic value of $.70 a share so I hope they don’t do another equity raise to raise cash at these elevated levels
This is just the complete wrong way to look at it. They are using their inflated stock price to increase their ability to raise cash to help build the case for a company w/o JNJ. Think, if JNJ drops them and they have no cash to fund the "pipeline" and the equity is pretty much worthless (sub $1), but if they raise a cash to fund this pipeline the equity is worth $1-$2 when JNJ invariably drops them. The CEO prepared investors for the JNJ drop when stating they can survive w/o JNJ. This is business as usual for another frothy biotech pump and dump
Wrong, more insanely under researched assertions by blind bulls. The form s3 was a replacement for their old shelf from 2015 09, which was set to expire shortly. Under this prior shelf they sold $50mm / $250mm April. The new shelf is for $100mm and they needed to file it now if they wanted to sell Bc when the SEC comes in an has comments lol.... I really hope they don’t access the capital markets Bc when JNJ drops them over the next 3 months the less cash to buoy the drop the better
Nope getting pushed and maybe not actually going public. This is the best asset in the space, looking to go public at least, and investor appetite has fallen off a cliff. I think that speaks volumes to the alternative plays
I added today! The mixed shelf should free up some float too!
Would add to short but no borrow ;(
Strong move? Mgmt is telling you their share price is overvalued so they’re diluting everyone to raise equity. If Mgmt this value of co is undervalued, they buyback shares, not sell shares
Fido owns everything them owning this literally means nothing
A) patience is a virtue not a venture lol
B) if you sold when I first posted you’re 25% more rich than you would be if you held.
C) I’ll probably cover another 25% or so down from here Bc this thing may squeeze again given high SI and how it literally squeezed on nothing in Q1. At which point I’ll put a Short back on
How do your trading shares make you money when the stock has only gone down since you started posted? Or are you shorting too?! You don’t need to teach me about investing I do it full time professionally and as you can see by my posts (track record) I am pretty good
Couple things
1) What? English please
2) I am happy to post all of my trade receipts just tell me how
3) I started posting on GERN at $4.5 and it is $3.4 so ignoring me lost 25%? Not sure I follow your logic
This is a prime example of how out of touch with reality you are. Earnings are irrelevant here and CEO comments were horrific. Stock is down 8% in pre market
Good luck out there. Again, check my track record when I publicly say I'm short something... I'm extremely confident in JNJ ultimately dropping them, at which point the stock will plummet to Sub $1
I don't think this is a fraud but I know the drug is worthless based on mgmt and how their drug has been pulled for safety before. It's the same drug that they keep trying to test and it keeps failing. It's pretty simple bet if you read up on the company history. The mania that happened in Jan was extremely confusing and offered me a great opt to short the stock around $5
More confident in this one than LFIN, which I knew was a fraud
My cost is $5 a share so I think I'm actually up a good amount on my short and have no interest in covering this awful safety profile of a drug that JNJ will drop. Unlike your track record, which we don't need to get into, check mine. I haven't been wrong since posting on IHUB (KMAG BITCF LFIN TRTCD)